NASDAQ · Biotechnology

Immunic Inc (IMUX)

$6.99 -5.41%
45 In band Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$11.55-39.48%

Company profile

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune and inflammatory diseases. The company is headquartered in New York, New York.

SectorHealthcare
IndustryBiotechnology
Market cap$106.29M
P/E ratioNone
EPS$-3.83
Beta1.483
Dividend yield0.00%
52-week high$17.43
52-week low$5.06

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for IMUX

An email when IMUX closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 6:01 AM EST